Cargando…

Is memantine a potential therapeutic for Rett syndrome?

Memantine is a low-affinity, voltage-dependent, non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist. It is classified as a neuroprotective aminoadamantane. It does not cure or reverse Alzheimer's but it does effectively treat symptoms, slows the progression of the disease and allows...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bello, Olivia, Blair, Kelsey, Chapleau, Christopher, Larimore, Jennifer L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865366/ https://www.ncbi.nlm.nih.gov/pubmed/24381538 http://dx.doi.org/10.3389/fnins.2013.00245

Ejemplares similares

Trofinetide—a new chapter in rett syndrome’s treatment
por: Furqan, Muhammad
Publicado: (2023)

Therapeutic Potential of Transcranial Focused Ultrasound for Rett Syndrome
por: Tsai, Shih-Jen
Publicado: (2016)

Memantine Attenuates Cocaine and neuroHIV Neurotoxicity in the Medial Prefrontal Cortex
por: Du, Congwu, et al.
Publicado: (2022)

Effects of baicalein with memantine on aluminium chloride-induced neurotoxicity in Wistar rats
por: Jadhav, Ratnakar, et al.
Publicado: (2023)

The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer’s Disease Patients and Its Consequence to Oxidative Stress Biomarkers
por: Valis, Martin, et al.
Publicado: (2019)

Rett Syndrome: Genes, Synapses, Circuits, and Therapeutics
por: Banerjee, Abhishek, et al.
Publicado: (2012)

Alternative Therapeutic Intervention for Individuals with Rett Syndrome
por: Lotan, Meir
Publicado: (2007)

Visual Evoked Potentials in Rett Syndrome
por: Millichap, J. Gordon
Publicado: (2015)

Rett syndrome
por: Sitholey, Prabhat, et al.
Publicado: (2005)

IGF1 as a Potential Treatment for Rett Syndrome: Safety Assessment in Six Rett Patients
por: Pini, Giorgio, et al.
Publicado: (2012)

Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats
por: Bali, Zsolt Kristóf, et al.
Publicado: (2019)

Comparison of Donepezil, Memantine, Melatonin, and Liuwei Dihuang Decoction on Behavioral and Immune Endocrine Responses of Aged Senescence-Accelerated Mouse Resistant 1 Mice
por: Zeng, Ju, et al.
Publicado: (2020)

Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology
por: Geerts, Hugo, et al.
Publicado: (2015)

JNK signaling provides a novel therapeutic target for Rett syndrome
por: Musi, Clara Alice, et al.
Publicado: (2021)

A review of the Rett Syndrome Behaviour Questionnaire and its utilization in the assessment of symptoms associated with Rett syndrome
por: Percy, Alan K., et al.
Publicado: (2023)

Sleep Disorders in Rett Syndrome and Rett-Related Disorders: A Narrative Review
por: Tascini, Giorgia, et al.
Publicado: (2022)

Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome
por: Musokhranova, Uliana, et al.
Publicado: (2023)

Synaptic Determinants of Rett Syndrome
por: Boggio, Elena M., et al.
Publicado: (2010)

Developmental Dynamics of Rett Syndrome
por: Feldman, Danielle, et al.
Publicado: (2016)

Hand Stereotypies in Rett Syndrome
por: Ferreira, Matheus G., et al.
Publicado: (2020)

Correcting Scoliosis in Rett Syndrome
por: Rocos, Brett, et al.
Publicado: (2021)

Gene therapy for Rett syndrome
por: Bassuk, Alexander G.
Publicado: (2021)

Sensory Integration and Functional Reaching in Children With Rett Syndrome/Rett-Related Disorders
por: Drobnyk, Wendy, et al.
Publicado: (2019)

Glial Dysfunction in MeCP2 Deficiency Models: Implications for Rett Syndrome
por: Kahanovitch, Uri, et al.
Publicado: (2019)

Expanding the MECP2 network using comparative genomics reveals potential therapeutic targets for Rett syndrome
por: Unterman, Irene, et al.
Publicado: (2021)

Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism
por: Chapleau, Christopher A., et al.
Publicado: (2009)

Neurobiologically-based treatments in Rett syndrome: opportunities and challenges
por: Kaufmann, Walter E., et al.
Publicado: (2016)

Gait Initiation in Children with Rett Syndrome
por: Isaias, Ioannis Ugo, et al.
Publicado: (2014)

RETT'S SYNDROME : A CASE REPORT
por: Gupta, Vinay
Publicado: (2001)

A perspective on “cure” for Rett syndrome
por: Clarke, Angus John, et al.
Publicado: (2018)

miR-21, Mediator, and Potential Therapeutic Target in the Cardiorenal Syndrome
por: Huang, Cheng-Kai, et al.
Publicado: (2020)

Clinical and Preclinical Evidence for M(1) Muscarinic Acetylcholine Receptor Potentiation as a Therapeutic Approach for Rett Syndrome
por: Smith, Mackenzie, et al.
Publicado: (2022)

Improving clinical trial readiness to accelerate development of new therapeutics for Rett syndrome
por: Leonard, Helen, et al.
Publicado: (2022)

Genetic and Epileptic Features in Rett Syndrome
por: Kim, Hyo Jeong, et al.
Publicado: (2012)

Clinical Characteristics of Children with Rett Syndrome
por: Han, Zee-A, et al.
Publicado: (2012)

Inflammatory Lung Disease in Rett Syndrome
por: De Felice, Claudio, et al.
Publicado: (2014)

Tackling the respiratory abnormalities of Rett syndrome
Publicado: (2014)

Dendritic spine dysgenesis in Rett syndrome
por: Xu, Xin, et al.
Publicado: (2014)

Subclinical Inflammatory Status in Rett Syndrome
por: Cortelazzo, Alessio, et al.
Publicado: (2014)

Treatments for cardiac arrhythmias in Rett syndrome
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9pscuu460pm0mgf3dsk16srv9e